Friday, May 27, 2016

BRIEF-AstraZeneca announces positive results in breast cancer trial

* Announced positive results from phase III falcon trial

comparing faslodex 500mg (fulvestrant) to arimidex 1mg

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)